跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12 条关于
“Waskyra”
全部
12
临床试验
0
药物
0
机构
1
资讯
11
10个月前
European Regulators Recommend Approval for Waskyra Gene Therapy for Rare Wiskott-Aldrich Syndrome
10个月前
EMA Recommends First Gene Therapy for Wiskott-Aldrich Syndrome
9个月前
FDA Approves First Gene Therapy for Wiskott-Aldrich Syndrome, Marking Historic Milestone for Non-Profit Drug Development
9个月前
FDA Approves First Gene Therapy for Wiskott-Aldrich Syndrome
去年
Morgan Lewis Advises Ankyra Therapeutics on Expanded Collaboration with Johnson & Johnson
去年
Ankyra Therapeutics Doses First Patient with Visceral Tumor in Phase 1 ANCHOR Trial of ANK-101
去年
Ankyra Therapeutics Doses First Patient in Visceral Tumor Study with ANK-101
9个月前
Ankyra Therapeutics Appoints Sailaja Battula as Chief Scientific Officer to Lead Immuno-Oncology Pipeline
去年
Ankyra Therapeutics Reports Promising Phase 1 Data for Anchored IL-12 Drug Conjugate in Solid Tumors
7个月前
Ankyra Therapeutics Unveils First-in-Class CD137-Anchored Immunotherapy ANK-203 with Promising Preclinical Anti-Tumor Activity
第 1 页,共 2 页
上一页
下一页